Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077053

« Back to Dashboard

NDA 077053 describes RIBAVIRIN, which is a drug marketed by Casi Pharms Inc, Teva, Zydus Pharms Usa, Navinta Llc, Aurobindo Pharma, Kadmon Pharms Llc, Sandoz, and Sandoz Inc, and is included in ten NDAs. It is available from ten suppliers. Additional details are available on the RIBAVIRIN profile page.

The generic ingredient in RIBAVIRIN is ribavirin. There are fifteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ribavirin profile page.

Summary for 077053

Tradename:	RIBAVIRIN
Applicant:	Teva
Ingredient:	ribavirin
Patents:	0
Therapeutic Class:	Antivirals
Formulation / Manufacturing:	see details

Medical Subject Heading (MeSH) Categories for 077053

Antimetabolites
Antiviral Agents

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	200MG
Approval Date:	Dec 5, 2005	TE:	AB	RLD:	No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture

Harvard Business School

Chinese Patent Office

Johnson and Johnson

US Department of Justice

AstraZeneca

QuintilesIMS

Cerilliant

Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.